XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement Of Cash Flows
 9 Months Ended
Sep. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (21,421,515)
Adjustments to reconcile net loss to net cash used in operating activities:  
General and administrative expenses paid by related party under promissory note 1,000
Income from investments held in Trust Account (98,658)
Loss upon issuance of private placement warrants 14,062,000
Offering costs associated with derivative warrant liabilities 710,745
Change in fair value of derivative warrant liabilities (705,000)
Legal expenses deferred until business combination 2,361,156
Changes in operating assets and liabilities:  
Prepaid expenses (50,208)
Accounts payable 74,281
Accrued expenses 3,815,044
Franchise tax payable 150,050
Net cash used in operating activities (3,462,261)
Cash Flows from Investing Activities  
Cash deposited in Trust Account (345,000,000)
Net cash used in investing activities (345,000,000)
Cash Flows from Financing Activities:  
Proceeds from loans from related parties 362,292
Repayment of loans from related parties (1,116,142)
Proceeds received from initial public offering, gross 345,000,000
Proceeds received from private placement 8,900,000
Offering costs paid (6,969,070)
Net cash provided by financing activities 348,538,236
Net increase in cash 75,975
Cash—beginning of the period 0
Cash—end of the period 75,975
Supplemental disclosure of noncash activities:  
Offering costs included in accounts payable 39,194
Offering costs included in accrued expenses 85,000
Offering costs paid by related party under promissory note 439,100
Prepaid expenses paid by related party under promissory note 425,000
Reversal of accrued expenses 50,000
Deferred underwriting commissions in connection with the initial public offering 12,075,000
Deferred legal fees $ 2,361,156